The Expression of Plasmacytoid Dendritic Cells and TLR7/9-MyD88-IRAKs Pathway in Chronic Eczema Lesions

References

• Navarrete-Rodríguez EM, Del-Río-Navarro BE, Reyes Noriega N, et al. Have the prevalence of eczema symptoms increased in the Mexican pediatric population? Prevalence and associated factors according to Global Asthma Network Phase I. World Allergy Organ J. 2022;15(11):100710. doi:10.1016/j.waojou.2022.100710
   PubMed Web of Science ®Google Scholar
• Zhang G, Gong X, Zhu B, Liu C, Jing L, Jinyu X. 2019年中国医学科学院皮肤病医院门诊病种分析 [Patterns of skin diseases among outpatients attending Hospital of Dermatology of Chinese Academy of Medical Sciences in 2019]. Chin J Dermatol. 2022;55(2):150–152. Chinese.
   Google Scholar
• Mortimer K, Lesosky M, García-Marcos L, et al.; Global Asthma Network Phase I Study Group. The burden of asthma, hay fever and eczema in adults in 17 countries: GAN Phase I study. Eur Respir J. 2022;60(3):2102865. doi:10.1183/13993003.02865-2021
   PubMed Web of Science ®Google Scholar
• Juan W, Yinping Z, Baizhan L, et al. Eczema, facial erythema, and seborrheic dermatitis symptoms among young adults in China in relation to ambient air pollution, climate, and home environment. Indoor Air. 2021;32(1):e12918. doi:10.1111/ina.12918
   PubMed Web of Science ®Google Scholar
• Bieber T, Novak N, Herrmann N, Koch S. Erratum to: role of dendritic cells in atopic dermatitis: an update. Clin Rev Allergy Immunol. 2011;41(3):254–258. doi:10.1007/s12016-010-8224-0
   PubMed Web of Science ®Google Scholar
• Nakashima C, Yanagihara S, Otsuka A. Innovation in the treatment of atopic dermatitis: emerging topical and oral Janus kinase inhibitors. Allergol Int. 2021;71(1):40–46. doi:10.1016/j.alit.2021.10.004
   PubMed Web of Science ®Google Scholar
• Aikaterini T, Maria K, George K, et al. The JAK/STAT pathway and its selective inhibition in the treatment of atopic dermatitis: a systematic review. J Clin Med. 2022;11(15):4431. doi:10.3390/jcm11154431
   PubMed Web of Science ®Google Scholar
• Krzysztof S, Magdalena T, Nowicki Roman J. JAK-STAT inhibitors in atopic dermatitis from pathogenesis to clinical trials results. Microorganisms. 2020;8(11):1743. doi:10.3390/microorganisms8111743
   PubMed Web of Science ®Google Scholar
• Aranez V, Ambrus Jr J. Immunologic adverse effects of biologics for the treatment of atopy. Clin Rev Allergy Immunol. 2019;59(2):220–230. doi:10.1007/s12016-019-08739-8
   Web of Science ®Google Scholar
• Damsin T, Libon F, Nikkels AF, Dezfoulian B. Dermatite atopique : la révolution thérapeutique est en marche [Atopic dermatitis: the therapeutic revolution is underway]. Rev Med Liege. 2022;77(5–6):377–383. French.
   PubMedGoogle Scholar
• Dzionek A, Fuchs A, Schmidt P, et al. BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J Immunol. 2000;165(11):6037–6046. doi:10.4049/jimmunol.165.11.6037
   PubMed Web of Science ®Google Scholar
• Fraga Garth R, Peter C. Plasmacytoid dendritic cells in keratoacanthoma and squamous cell carcinoma: a blinded study of CD123 as a diagnostic marker. J Cutan Pathol. 2020;47(1):17–21. doi:10.1111/cup.13573
   PubMed Web of Science ®Google Scholar
• Narittee S, Aung Phyu P, Cameron YC, et al. Dual expression of TCF4 and CD123 is highly sensitive and specific for blastic plasmacytoid dendritic cell neoplasm. Am J Surg Pathol. 2019;43(10):1429–1437. doi:10.1097/PAS.0000000000001316
   PubMed Web of Science ®Google Scholar
• Tang Y, Qiang Z, Rui H, Wei L, Xiaohua T, Hao C. 寻常型银屑病皮损组织中浆细胞样树突状细胞和TLR7/9通路表达的研究 [Distribution of plasma cell-like dendritic cells and expression of TLR7/9 pathway related molecules in psoriasis vulgaris]. Zhejiang Med J. 2020;42(6):533–535, 539, 647–648. Chinese.
   Google Scholar
• Tang Y, Xiaoxia Z, Rui H, Qiang Z, Hao C. Expression of Langerhans cell and plasmacytoid dendritic cell markers, and toll-like receptor 7/9 signaling pathway proteins in verruca vulgaris lesions. Medicine. 2020;99(8):e19214. doi:10.1097/MD.0000000000019214
   PubMed Web of Science ®Google Scholar
• Lin JY, Wu WH, Chen JS, et al. Plasmacytoid dendritic cells suppress Th2 responses induced by epicutaneous sensitization. Immunol Cell Biol. 2020;98(3):215–228. doi:10.1111/imcb.12315
   PubMed Web of Science ®Google Scholar
• Ghanem Mustafa H, Shih Andrew J, Houman K, et al. Proteomic and single-cell transcriptomic dissection of human plasmacytoid dendritic cell response to influenza virus. Front Immunol. 2022;13:814627. doi:10.3389/fimmu.2022.814627
   PubMed Web of Science ®Google Scholar
• Werfel T, Irvine AD, Bangert C, et al. An integrated analysis of herpes virus infections from eight randomized clinical studies of baricitinib in adults with moderate-to-severe atopic dermatitis. J Eur Acad Dermatol Venereol. 2022;36(9):1486–1496. doi:10.1111/jdv.18193
   PubMed Web of Science ®Google Scholar
• Maureen M, De La Cruz Nydia C, Matthias R, Lisa W. Herpes simplex virus 1 can bypass impaired epidermal barriers upon ex vivo infection of skin from atopic dermatitis patients. J Virol. 2022;96(17):e0086422. doi:10.1128/jvi.00864-22
   PubMed Web of Science ®Google Scholar
• Wan J, Shin DB, Syed MN, Abuabara K, Lemeshow AR, Gelfand JM. Risk of herpesvirus, serious, and opportunistic infections in atopic dermatitis: a population-based cohort study. Br J Dermatol. 2021;186(4):664–672. doi:10.1111/bjd.20887
   Google Scholar
• Yim LY, Lau CS, Vera Sau-Fong C. Heightened TLR7/9-induced IL-10 and CXCL13 production with dysregulated NF-ҝB activation in CD11chiCD11b+ dendritic cells in NZB/W F1 mice. Int J Mol Sci. 2019;20(18):4639. doi:10.3390/ijms20184639
   PubMed Web of Science ®Google Scholar
• Toll-Like KV. Receptors in adaptive immunity. Handb Exp Pharmacol. 2021;225(3):510–519. doi:10.1007/164_2021_543
   Google Scholar
• Yoon W, Kim EJ, Park Y, Kim S, Park YK, Yoo Y. Bacterially delivered miRNA-mediated toll-like receptor 8 gene silencing for combined therapy in a murine model of atopic dermatitis: therapeutic effect of miRTLR8 in AD. Microorganisms. 2021;9(8):1715. doi:10.3390/microorganisms9081715
   PubMed Web of Science ®Google Scholar
• Obayed UM, Sweet Matthew J, Ashley M, Stuart K, Bostjan K. TRIF-dependent TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic target. Journal of leukocyte biology. 2016; 100(1):27–45. DecauxG. Long-term treatment of patients with inappropriate secretion of antidiuretic hormone by the vasopressin receptor antagonist conivaptan, urea, or furosemide. Am J Med. 2001;110:582–584. doi:10.1016/s0002-9343(01)00678-7
   PubMedGoogle Scholar
• Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol. 2010;11(5):373–384. doi:10.1038/ni.1863
   PubMed Web of Science ®Google Scholar
• Kang YM, Kim HM, Lee M, An HJ. Oleanolic acid alleviates atopic dermatitis-like responses in vivo and in vitro. Int J Mol Sci. 2021;22:12000. doi:10.3390/ijms222112000
   PubMed Web of Science ®Google Scholar
• Li G, Wu H, Sun L, et al. (-)-α-bisabolol alleviates atopic dermatitis by inhibiting MAPK and NF-κB signaling in mast cell. Molecules. 2022;27(13):3985. doi:10.3390/molecules27133985
   PubMed Web of Science ®Google Scholar
• Uematsu S, Takeuchi O, Kato H, et al. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction. J Exp Med. 2005;201(6):915–923. doi:10.1084/jem.20042372
   PubMed Web of Science ®Google Scholar
• Duan T, Du Y, Xing C, Wang HY, Wang RF. Toll-like receptor signaling and its role in cell-mediated immunity. Front Immunol. 2022;13:812774. doi:10.3389/fimmu.2022.812774
   PubMedGoogle Scholar
• Melissa S, Marco C. The multifaceted biology of plasmacytoid dendritic cells. Nat Rev Immunol. 2015;15(8):471–485. doi:10.1038/nri3865
   PubMed Web of Science ®Google Scholar
• Yutaro K, Himanshu K, Shohei K, Taro K, Osamu T, Shizuo A. Cutting edge: TLR-Dependent viral recognition along with type I IFN positive feedback signaling masks the requirement of viral replication for IFN-{alpha} production in plasmacytoid dendritic cells. J Immunol. 2009;182(7):3960–3964. doi:10.4049/jimmunol.0804315
   PubMed Web of Science ®Google Scholar